Hydromer, Inc. has announced a strategic investment from JMEDTECH alongside the formation of a new Board of Directors, positioning the company for accelerated global expansion in medical device coating technologies. This partnership establishes what company leadership describes as a future-oriented global medical device coating platform integrating UV-curable and thermal-cure coating systems with advanced coating equipment and regionalized services.
The collaboration represents a significant development in medical device manufacturing infrastructure, creating a comprehensive solution that spans research and development, validation, and mass production capabilities. By uniting Hydromer's 44 years of hydrophilic, thromboresistant, and antimicrobial coating expertise with JMEDTECH's resources, the partnership establishes a mirror-delivery network covering major medical device markets across Asia and the Americas.
This strategic move enhances supply chain resilience and responsiveness at a time when global medical device manufacturers face increasing pressure to secure reliable coating services. The combined platform addresses critical industry needs for consistent quality, regulatory compliance, and scalable production capacity across multiple geographic regions. Michael Torti, who continues as CEO and Director, emphasized the significance of this partnership for the medical device industry.
"Our company couldn't be more pleased to join forces with JMEDTECH and its fine leaders," Torti stated. "For over 40 years, Hydromer has been an innovator in the surface conversion coatings industry and now, with the support of one of the most innovative companies in our industry, together we will bring perhaps the broadest range of coating capabilities to the Global Medical Device marketplace."
The restructured Board of Directors, led by Chairman Jacqueline Zhang alongside Torti, brings strengthened leadership and industry expertise as Hydromer enters its next growth phase. The company maintains its ISO 9001:2015 certification and compliance with Good Manufacturing Practice standards, ensuring continued quality assurance for medical device manufacturers worldwide. This partnership not only amplifies Hydromer's technological and brand influence but also marks a critical milestone in JMEDTECH's global expansion strategy.
The enhanced coating platform addresses growing demand for sophisticated surface modification technologies that improve device performance, patient safety, and treatment outcomes. Medical devices requiring specialized coatings include cardiovascular implants, surgical instruments, diagnostic equipment, and various implantable devices where surface properties significantly impact clinical performance. The combined capabilities position the partnership to serve evolving regulatory requirements and technological advancements across global healthcare markets.
